Results 1 - 10 of 89 for Imatinib
  1. Imatinib is used to treat certain types of leukemia (cancer that begins in the white blood cells) ... other cancers and disorders of the blood cells. Imatinib is also used to treat certain types of ...
  2. ... with tumors that were not treated successfully with imatinib (Gleevec) or people who cannot take imatinib. Sunitinib is also used to treat advanced renal ...
  3. ... whose disease could not be treated successfully with imatinib (Gleevec) or adults who cannot take imatinib. Nilotinib is also used to treat certain types ...
  4. ... and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med. ... Müller-Tidow C, Reiter A, Koschmieder S. Novel imatinib-sensitive PDGFRA-activating point mutations in hypereosinophilic syndrome ...
  5. ... and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med. ...
  6. ... Schultheis B, Cross NC, Goldman JM. Response to imatinib mesylate in patients with chronic myeloproliferative diseases with ...
  7. ... no longer benefit from other leukemia medications including imatinib (Gleevec) or in those who cannot take these ...
  8. Chronic myeloid leukemia is a slow-growing cancer of the blood-forming tissue (bone marrow). Normal bone marrow produces red blood cells (erythrocytes) that carry ...
  9. ... adults who have previously received other medications, including imatinib (Gleevec). Ripretinib is in a class of medications ...
  10. The ABL1 gene provides instructions for making a protein involved in many processes in cells throughout the body. The ABL1 protein functions as a kinase, ...
previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · next